| Contributors |
|
xv | |
| Reviewers |
|
xvii | |
| Preface |
|
xix | |
|
Section I. The Essentials |
|
|
1 | (212) |
|
Assessment of Critically Ill Patients and Families |
|
|
3 | (14) |
|
|
|
|
|
3 | (1) |
|
|
|
4 | (1) |
|
|
|
4 | (1) |
|
Comprehensive Admission Assessment |
|
|
4 | (1) |
|
|
|
4 | (1) |
|
Prearrival Assessment: Before the Action Begins |
|
|
4 | (1) |
|
Admission Quick Check Assessment: The First Few Minutes |
|
|
5 | (2) |
|
|
|
6 | (1) |
|
Circulation and Cerebral Perfusion |
|
|
6 | (1) |
|
|
|
6 | (1) |
|
Drugs and Diagnostic Tests |
|
|
6 | (1) |
|
|
|
7 | (1) |
|
Comprehensive Admission Assessment |
|
|
7 | (7) |
|
|
|
8 | (1) |
|
|
|
8 | (1) |
|
Physical Assessment by Body System |
|
|
9 | (3) |
|
|
|
12 | (2) |
|
|
|
14 | (3) |
|
Planning Care for Critically Ill Patients and Families |
|
|
17 | (20) |
|
|
|
Multidisciplinary Plan of Care and Critical Pathways |
|
|
17 | (1) |
|
Prevention of Common Complications |
|
|
18 | (8) |
|
|
|
18 | (1) |
|
|
|
18 | (5) |
|
Hospital-Acquired Infections |
|
|
23 | (1) |
|
|
|
24 | (1) |
|
Sleep Pattern Disturbances |
|
|
24 | (1) |
|
|
|
25 | (1) |
|
Patient and Family Education |
|
|
26 | (2) |
|
Assessment of Learning Readiness |
|
|
26 | (1) |
|
Strategies to Address Patient and Family Education |
|
|
27 | (1) |
|
|
|
27 | (1) |
|
|
|
28 | (1) |
|
Transporting the Critically Ill Patient |
|
|
29 | (3) |
|
Assessment of Risk for Complications |
|
|
29 | (1) |
|
Level of Care Required During Transport |
|
|
30 | (1) |
|
|
|
31 | (1) |
|
|
|
31 | (1) |
|
|
|
32 | (1) |
|
Transitioning to the Next Stage of Care |
|
|
32 | (1) |
|
Supporting Patients and Families During the Dying Process |
|
|
33 | (4) |
|
Interpretation and Management of Basic Cardiac Rhythms |
|
|
37 | (28) |
|
|
|
|
|
37 | (1) |
|
ECG Waveforms, Complexes, and Intervals |
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
38 | (1) |
|
|
|
39 | (1) |
|
|
|
39 | (3) |
|
Determination of the Heart Rate |
|
|
42 | (1) |
|
Determination of the Cardiac Rhythm |
|
|
42 | (1) |
|
|
|
43 | (1) |
|
Rhythms Originating in the Sinus Node |
|
|
43 | (2) |
|
|
|
44 | (1) |
|
|
|
44 | (1) |
|
|
|
45 | (1) |
|
|
|
45 | (1) |
|
Arrhythmias Originating in the Atria |
|
|
45 | (4) |
|
Premature Atrial Complexes |
|
|
46 | (1) |
|
Wandering Atrial Pacemaker |
|
|
46 | (1) |
|
|
|
47 | (1) |
|
|
|
47 | (1) |
|
|
|
48 | (1) |
|
Arrhythmias Originating in the Atrioventricular Junction |
|
|
49 | (1) |
|
Premature Junctional Complexes |
|
|
50 | (1) |
|
Junctional Rhythm, Accelerated Junctional Rhythm, and Junctional Tachycardia |
|
|
50 | (1) |
|
Arrhythmias Originating in the Ventricles |
|
|
50 | (4) |
|
Premature Ventricular Complexes |
|
|
51 | (1) |
|
Ventricular Rhythm and Accelerated Ventricular Rhythm |
|
|
51 | (1) |
|
|
|
52 | (1) |
|
|
|
53 | (1) |
|
|
|
53 | (1) |
|
|
|
54 | (3) |
|
First-Degree Atrioventricular Block |
|
|
54 | (1) |
|
Second-Degree Atrioventricular Block |
|
|
54 | (2) |
|
High-Grade Atrioventricular Block |
|
|
56 | (1) |
|
Third-Degree Atrioventricular Block (Complete Block) |
|
|
56 | (1) |
|
|
|
57 | (3) |
|
|
|
57 | (1) |
|
|
|
57 | (1) |
|
|
|
57 | (1) |
|
Components of a Pacing System |
|
|
57 | (1) |
|
Basics of Pacemaker Operation |
|
|
58 | (2) |
|
ECG Characteristics of Paced Rhythms |
|
|
60 | (1) |
|
Initiating Transvenous Ventricular Pacing |
|
|
60 | (1) |
|
Initiating Epicardial Pacing |
|
|
60 | (1) |
|
External (Transcutaneous) Pacemakers |
|
|
60 | (1) |
|
Defibrillation and Cardioversion |
|
|
60 | (5) |
|
|
|
60 | (1) |
|
Automatic External Defibrillators |
|
|
61 | (1) |
|
|
|
62 | (3) |
|
|
|
65 | (46) |
|
|
|
|
|
65 | (7) |
|
|
|
65 | (2) |
|
Components of Cardiac Output/Cardiac Index |
|
|
67 | (1) |
|
Stroke Volume and Stroke Volume Index |
|
|
68 | (1) |
|
Factors Affecting Stroke Volume/Stroke Volume Index |
|
|
68 | (4) |
|
Basic Components of Hemodynamic Monitoring Systems |
|
|
72 | (2) |
|
Pulmonary Artery Catheter |
|
|
72 | (1) |
|
|
|
72 | (1) |
|
|
|
72 | (1) |
|
|
|
73 | (1) |
|
|
|
74 | (1) |
|
Pressure Bag and Flush Device |
|
|
74 | (1) |
|
|
|
74 | (1) |
|
Obtaining Accurate Hemodynamic Values |
|
|
74 | (3) |
|
|
|
74 | (1) |
|
Leveling the Transducer to the Catheter Tip |
|
|
75 | (2) |
|
Calibration of the Transducer/Amplifier System |
|
|
77 | (1) |
|
Ensuring Accurate Waveform Transmission |
|
|
77 | (1) |
|
Insertion and Removal of Catheters |
|
|
77 | (7) |
|
Pulmonary Artery Catheters |
|
|
77 | (3) |
|
|
|
80 | (4) |
|
Obtaining and Interpreting Hemodynamic Waveforms |
|
|
84 | (13) |
|
|
|
84 | (1) |
|
|
|
84 | (7) |
|
Artifacts in Hemodynamic Waveforms: Respiratory Influence |
|
|
91 | (1) |
|
|
|
92 | (5) |
|
Continuous Mixed Venous Oxygen Monitoring |
|
|
97 | (2) |
|
Svo2 Monitoring Principles |
|
|
97 | (1) |
|
Selected Examples of Clinical Applications |
|
|
98 | (1) |
|
Right Ventricular Ejection Fraction Catheters |
|
|
99 | (1) |
|
|
|
99 | (1) |
|
|
|
99 | (1) |
|
Minimally Invasive Hemodynamic Monitoring |
|
|
100 | (2) |
|
|
|
100 | (1) |
|
Esophageal Doppler Cardiac Output |
|
|
100 | (1) |
|
Carbon Dioxide Rebreathing |
|
|
100 | (1) |
|
|
|
100 | (1) |
|
|
|
101 | (1) |
|
Application of Hemodynamic Parameters |
|
|
102 | (9) |
|
Low Cardiac Output States |
|
|
102 | (4) |
|
High Cardiac Output States |
|
|
106 | (5) |
|
Airway and Ventilatory Management |
|
|
111 | (34) |
|
|
|
Respiratory Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
111 | (7) |
|
Arterial Blood Gas Monitoring |
|
|
111 | (1) |
|
|
|
112 | (4) |
|
Venous Blood Gas Monitoring |
|
|
116 | (1) |
|
|
|
116 | (2) |
|
Assessing Pulmonary Function |
|
|
118 | (1) |
|
|
|
118 | (7) |
|
|
|
118 | (2) |
|
|
|
120 | (1) |
|
|
|
120 | (5) |
|
|
|
125 | (4) |
|
|
|
125 | (2) |
|
|
|
127 | (2) |
|
Basic Ventilatory Management |
|
|
129 | (16) |
|
|
|
129 | (1) |
|
|
|
129 | (3) |
|
|
|
132 | (3) |
|
|
|
135 | (1) |
|
Weaning From Short-Term Mechanical Ventilation |
|
|
136 | (2) |
|
Troubleshooting Ventilators |
|
|
138 | (1) |
|
|
|
139 | (2) |
|
|
|
141 | (4) |
|
Pain, Sedation, and Neuromuscular Blockade Management |
|
|
145 | (20) |
|
|
|
|
|
Physiologic Mechanisms of Pain |
|
|
145 | (2) |
|
|
|
145 | (2) |
|
|
|
147 | (1) |
|
|
|
147 | (1) |
|
|
|
147 | (1) |
|
|
|
148 | (1) |
|
A Multilevel Approach to Pain Management |
|
|
148 | (1) |
|
Nonsteroidal Anti-Inflammatory Drugs |
|
|
149 | (1) |
|
|
|
150 | (1) |
|
|
|
150 | (3) |
|
|
|
150 | (1) |
|
|
|
151 | (1) |
|
Patient-Controlled Analgesia |
|
|
151 | (1) |
|
Switching From IV to Oral Opioid Analgesia |
|
|
152 | (1) |
|
|
|
153 | (2) |
|
|
|
153 | (1) |
|
Epidural Local Anesthetics |
|
|
154 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
Relaxation and Sedation Techniques |
|
|
155 | (1) |
|
Deep Breathing and Progressive Relaxation |
|
|
156 | (1) |
|
|
|
156 | (1) |
|
Special Considerations for Pain Management in the Elderly |
|
|
156 | (1) |
|
|
|
157 | (1) |
|
|
|
157 | (1) |
|
|
|
157 | (2) |
|
|
|
157 | (1) |
|
|
|
158 | (1) |
|
Goals of Sedation, Monitoring, and Management |
|
|
159 | (1) |
|
Sedation Scales: Goals and Monitoring |
|
|
159 | (1) |
|
|
|
159 | (1) |
|
|
|
159 | (6) |
|
Neuromuscular Blocking Agents |
|
|
160 | (1) |
|
Monitoring and Management |
|
|
161 | (4) |
|
|
|
165 | (34) |
|
|
|
Medication Administration Methods |
|
|
165 | (2) |
|
|
|
165 | (1) |
|
Intramuscular or Subcutaneous |
|
|
165 | (1) |
|
|
|
166 | (1) |
|
|
|
166 | (1) |
|
|
|
166 | (1) |
|
Central Nervous System Pharmacology |
|
|
167 | (9) |
|
|
|
167 | (3) |
|
|
|
170 | (1) |
|
Neuromuscular Blocking Agents |
|
|
171 | (2) |
|
|
|
173 | (3) |
|
Cardiovascular System Pharmacology |
|
|
176 | (9) |
|
|
|
176 | (1) |
|
|
|
177 | (3) |
|
|
|
180 | (2) |
|
|
|
182 | (1) |
|
|
|
183 | (1) |
|
|
|
184 | (1) |
|
|
|
185 | (1) |
|
Anti-Infective Pharmacology |
|
|
185 | (2) |
|
|
|
185 | (1) |
|
|
|
186 | (1) |
|
|
|
186 | (1) |
|
|
|
187 | (1) |
|
|
|
187 | (1) |
|
|
|
187 | (1) |
|
Gastrointestinal Pharmacology |
|
|
188 | (2) |
|
|
|
188 | (1) |
|
Acute Peptic Ulcer Bleeding |
|
|
189 | (1) |
|
|
|
189 | (1) |
|
|
|
190 | (1) |
|
|
|
190 | (1) |
|
|
|
191 | (2) |
|
|
|
191 | (2) |
|
Direct Thrombin Inhibitors |
|
|
193 | (1) |
|
Glycoprotein IIb/IIa Inhibitor |
|
|
193 | (1) |
|
|
|
193 | (2) |
|
|
|
193 | (1) |
|
|
|
194 | (1) |
|
|
|
194 | (1) |
|
Special Dosing Considerations |
|
|
195 | (4) |
|
Continuous Renal Replacement Therapy |
|
|
195 | (1) |
|
Drug Disposition in the Elderly |
|
|
195 | (1) |
|
Therapeutic Drug Monitoring |
|
|
195 | (4) |
|
Ethical and Legal Considerations |
|
|
199 | (14) |
|
|
|
The Foundation for Ethical Decision Making |
|
|
199 | (5) |
|
Professional Codes and Standards |
|
|
199 | (1) |
|
Position Statement and Guidelines |
|
|
200 | (1) |
|
|
|
200 | (1) |
|
|
|
200 | (1) |
|
|
|
201 | (2) |
|
|
|
203 | (1) |
|
|
|
204 | (1) |
|
The Process of Ethical Analysis |
|
|
204 | (1) |
|
|
|
204 | (1) |
|
|
|
204 | (1) |
|
|
|
205 | (1) |
|
|
|
205 | (1) |
|
Contemporary Ethical Issues |
|
|
205 | (4) |
|
|
|
205 | (1) |
|
|
|
205 | (1) |
|
|
|
206 | (1) |
|
|
|
207 | (2) |
|
|
|
209 | (1) |
|
Building an Ethical Environment |
|
|
209 | (4) |
|
|
|
209 | (1) |
|
Provide Information and Clarify Issues |
|
|
209 | (1) |
|
|
|
210 | (1) |
|
Engage in Collaborative Decision Making |
|
|
210 | (3) |
|
Section II. Pathologic Conditions |
|
|
213 | (176) |
|
|
|
215 | (32) |
|
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
215 | (3) |
|
|
|
215 | (1) |
|
|
|
215 | (1) |
|
Percutaneous Coronary Interventions |
|
|
216 | (1) |
|
Other Percutaneous Coronary Interventions |
|
|
217 | (1) |
|
|
|
218 | (29) |
|
Acute Ischemic Heart Disease |
|
|
218 | (12) |
|
|
|
230 | (8) |
|
|
|
238 | (5) |
|
|
|
243 | (4) |
|
|
|
247 | (20) |
|
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
247 | (5) |
|
|
|
247 | (4) |
|
Computed Tomography and Magnetic Resonance Imaging |
|
|
251 | (1) |
|
|
|
252 | (1) |
|
|
|
252 | (15) |
|
Acute Respiratory Failure |
|
|
252 | (4) |
|
Acute Respiratory Distress Syndrome |
|
|
256 | (2) |
|
Acute Respiratory Failure in the Patient With Chronic Obstructive Pulmonary Disease |
|
|
258 | (2) |
|
|
|
260 | (3) |
|
|
|
263 | (4) |
|
|
|
267 | (12) |
|
|
|
|
|
267 | (7) |
|
Sepsis and Multiple Organ Dysfunction Syndrome |
|
|
267 | (7) |
|
|
|
274 | (5) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
274 | (5) |
|
|
|
279 | (26) |
|
|
|
|
|
279 | (8) |
|
|
|
279 | (1) |
|
|
|
280 | (1) |
|
|
|
281 | (2) |
|
|
|
283 | (1) |
|
|
|
283 | (2) |
|
Cranial Nerve Assessment and Assessment of Brainstem Function |
|
|
285 | (1) |
|
Vital Sign Alterations in Neurologic Dysfunction |
|
|
286 | (1) |
|
Death by Neurologic Criteria |
|
|
287 | (1) |
|
|
|
287 | (3) |
|
|
|
287 | (1) |
|
|
|
288 | (1) |
|
Magnetic Resonance Imaging |
|
|
288 | (1) |
|
|
|
289 | (1) |
|
Transcranial Doppler Ultrasound |
|
|
290 | (1) |
|
|
|
290 | (1) |
|
|
|
290 | (1) |
|
Intracranial Pressure: Concepts and Monitoring |
|
|
290 | (6) |
|
|
|
291 | (1) |
|
Causes of Increased Intracranial Pressure |
|
|
291 | (5) |
|
|
|
296 | (3) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
296 | (1) |
|
|
|
297 | (2) |
|
|
|
299 | (1) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
299 | (1) |
|
|
|
300 | (1) |
|
|
|
300 | (1) |
|
Principles of Management of Intracerebral Hemorrhage |
|
|
300 | (1) |
|
|
|
300 | (2) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
300 | (1) |
|
|
|
300 | (1) |
|
Principles of Management of Seizures |
|
|
301 | (1) |
|
Infections of the Central Nervous System |
|
|
302 | (1) |
|
|
|
302 | (1) |
|
|
|
302 | (1) |
|
|
|
302 | (1) |
|
|
|
303 | (2) |
|
|
|
303 | (1) |
|
|
|
303 | (2) |
|
Hematology and Immunology Systems |
|
|
305 | (12) |
|
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
305 | (3) |
|
|
|
305 | (1) |
|
|
|
305 | (1) |
|
|
|
306 | (1) |
|
|
|
306 | (1) |
|
|
|
306 | (1) |
|
Total White Blood Cell Count |
|
|
306 | (1) |
|
White Blood Cell Differential |
|
|
306 | (1) |
|
|
|
307 | (1) |
|
Erythrocyte Sedimentation Rate |
|
|
307 | (1) |
|
|
|
307 | (1) |
|
Additional Tests and Procedures |
|
|
308 | (1) |
|
|
|
308 | (9) |
|
|
|
308 | (2) |
|
|
|
310 | (2) |
|
|
|
312 | (5) |
|
|
|
317 | (24) |
|
|
|
|
|
|
|
|
|
317 | (15) |
|
Acute Upper Gastrointestinal Bleeding |
|
|
317 | (8) |
|
|
|
325 | (5) |
|
|
|
330 | (1) |
|
Bowel Infarction/Obstruction |
|
|
331 | (1) |
|
Nutritional Support for Critically Ill Patients |
|
|
332 | (9) |
|
|
|
332 | (1) |
|
|
|
333 | (1) |
|
|
|
334 | (1) |
|
|
|
335 | (1) |
|
|
|
336 | (1) |
|
Osmolality or Hypertonicity of Formula |
|
|
336 | (1) |
|
|
|
337 | (1) |
|
Flow Rates and Hours of Infusion |
|
|
337 | (1) |
|
|
|
337 | (4) |
|
|
|
341 | (16) |
|
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
341 | (1) |
|
|
|
341 | (9) |
|
|
|
341 | (5) |
|
Life-Threatening Electrolyte Imbalances |
|
|
346 | (4) |
|
Renal Replacement Therapy |
|
|
350 | (7) |
|
|
|
351 | (1) |
|
Dialyzer/Hemofilters/Dialysate |
|
|
352 | (1) |
|
|
|
352 | (1) |
|
Indications for and Efficacy of Renal Replacement Therapy Modes |
|
|
352 | (3) |
|
General Renal Replacement Therapy Interventions |
|
|
355 | (2) |
|
|
|
357 | (14) |
|
|
|
Special Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
357 | (2) |
|
|
|
357 | (2) |
|
|
|
359 | (12) |
|
Hyperglycemic Emergencies |
|
|
359 | (5) |
|
|
|
364 | (1) |
|
Syndrome of Inappropriate Antidiuretic Hormone Secretion |
|
|
365 | (2) |
|
|
|
367 | (4) |
|
|
|
371 | (18) |
|
|
|
|
|
Specialized Assessment Techniques, Diagnostic Tests, and Monitoring Systems |
|
|
371 | (7) |
|
Primary and Secondary Trauma Survey Assessment |
|
|
371 | (3) |
|
|
|
374 | (2) |
|
|
|
376 | (1) |
|
Physiologic Consequences of Trauma |
|
|
377 | (1) |
|
Common Injuries in the Critically Ill Trauma Patient |
|
|
378 | (4) |
|
|
|
378 | (2) |
|
|
|
380 | (1) |
|
|
|
381 | (1) |
|
Complications of Traumatic Injury in Severe Multisystem Trauma |
|
|
382 | (3) |
|
Acute Respiratory Distress Syndrome |
|
|
384 | (1) |
|
|
|
385 | (1) |
|
Systemic Inflammatory Response Syndrome |
|
|
385 | (1) |
|
Psychological Consequences of Trauma |
|
|
385 | (4) |
|
Section III. Advanced Concepts in Caring for the Critically III Patient |
|
|
389 | (112) |
|
|
|
391 | (40) |
|
|
|
The 12-Lead Electrocardiogram |
|
|
391 | (20) |
|
|
|
396 | (3) |
|
|
|
399 | (2) |
|
Myocardial Ischemia, Injury, and Infarction |
|
|
401 | (6) |
|
|
|
407 | (4) |
|
Advanced Arrhythmia Interpretation |
|
|
411 | (8) |
|
Supraventricular Tachycardias |
|
|
412 | (3) |
|
Differentiating Wide QRS Beats and Rhythms |
|
|
415 | (4) |
|
|
|
419 | |
|
|
|
420 | (1) |
|
Choosing the Best Leads for ST-Segment Monitoring |
|
|
421 | |
|
|
|
418 | (13) |
|
Evaluating Pacemaker Function |
|
|
423 | (1) |
|
|
|
423 | (4) |
|
|
|
427 | (4) |
|
Advanced Cardiovascular Concepts |
|
|
431 | (32) |
|
|
|
|
|
431 | (32) |
|
|
|
431 | (5) |
|
|
|
436 | (5) |
|
|
|
441 | (2) |
|
|
|
443 | (3) |
|
|
|
446 | (6) |
|
Intra-Aortic Balloon Pump Therapy |
|
|
452 | (3) |
|
Ventricular Assist Devices |
|
|
455 | (8) |
|
Advanced Respiratory Concepts |
|
|
463 | (14) |
|
|
|
Advanced Modes of Mechanical Ventilation |
|
|
463 | (7) |
|
New Concepts: Mechanical Ventilation |
|
|
463 | (1) |
|
Volume Versus Pressure Ventilator |
|
|
464 | (5) |
|
Alternative Ventilator Options |
|
|
469 | (1) |
|
Weaning Patients From Long-Term Mechanical Ventilation |
|
|
470 | (7) |
|
|
|
470 | (1) |
|
|
|
471 | (1) |
|
Weaning Trials, Modes, and Methods |
|
|
471 | (1) |
|
Respiratory Fatigue, Rest, and Conditioning |
|
|
471 | (1) |
|
|
|
472 | (1) |
|
|
|
473 | (1) |
|
|
|
473 | (1) |
|
Systematic Institutional Initiatives for the Management of the LTMV Patient Population |
|
|
473 | (4) |
|
Advanced Neurologic Concepts |
|
|
477 | (24) |
|
|
|
|
|
477 | (4) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
477 | (1) |
|
|
|
477 | (2) |
|
|
|
479 | (2) |
|
|
|
481 | (6) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
481 | (4) |
|
|
|
485 | (1) |
|
|
|
485 | (2) |
|
Traumatic Spinal Cord Injury |
|
|
487 | (7) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
487 | (2) |
|
|
|
489 | (1) |
|
|
|
490 | (1) |
|
Future Spinal Cord Injury Treatment |
|
|
490 | (4) |
|
|
|
494 | (7) |
|
Etiology, Risk Factors, and Pathophysiology |
|
|
494 | (1) |
|
|
|
495 | (2) |
|
Advanced Technology: Brain Tissue Oxygen Monitoring |
|
|
497 | (4) |
|
Section IV. Key Reference Information |
|
|
501 | (60) |
|
|
|
503 | (2) |
|
|
|
|
|
505 | (14) |
|
|
|
Advanced Cardiac Life Support Algorithms |
|
|
519 | (10) |
|
|
|
Guidelines for the Transfer of Critically III Patients |
|
|
529 | (4) |
|
|
|
Transfers Within the Hospital |
|
|
529 | (1) |
|
|
|
529 | (1) |
|
Transport Equipment Requirements |
|
|
529 | (1) |
|
Monitoring During Transfer |
|
|
529 | (1) |
|
Pretransfer Coordination and Communication |
|
|
529 | (1) |
|
Transfers Between Hospitals |
|
|
530 | (3) |
|
|
|
530 | (1) |
|
Transport Medication Requirements |
|
|
530 | (1) |
|
|
|
530 | (1) |
|
Monitoring During Transfer |
|
|
531 | (1) |
|
|
|
532 | (1) |
|
Hemodynamic Monitoring Troubleshooting Guide |
|
|
533 | (6) |
|
|
|
Ventilatory Troubleshooting Guide |
|
|
539 | (12) |
|
|
|
|
|
Cardiac Rhythms, ECG Characteristics, and Treatment Guide |
|
|
551 | (10) |
|
|
| Index |
|
561 | |